<DOC>
	<DOCNO>NCT01222403</DOCNO>
	<brief_summary>This study evaluate safety influenza ( flu ) vaccine Korean men woman age 65 year old .</brief_summary>
	<brief_title>A Post-marketing Study Monitor Safety MF59-adjuvanted Influenza Vaccine Administered Korean Subjects Aged 65 Years Older</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>MF59 oil emulsion</mesh_term>
	<criteria>1 . Males female age 65 year day enrollment , eligible seasonal influenza vaccination . 2 . In judgement study doctor determine reasonable health consider age able comply study procedure . 1 . History serious reaction flu vaccine , material vaccine , egg ( include ovalbumin ) chicken protein . 2 . Receipt another ( inactivate ) vaccine within 2 week , receipt live vaccine within 4 week prior Study Day 1 , plan receive vaccination final study visit ( Day 29 vaccination ) . 3 . Any condition , opinion study doctor , might interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>